Influence of Intra-abdominal Ropivacaine 0.5% Spray on Postoperative Analgesia in Laparoscopic Surgery.

University of Liege

Status: Unknown

Conditions: Pain, Acute

Treatments: Drug: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery

Study type: Interventional

Funder types: Other

Identifiers

NCT05173090

Ropicoelio

Details and patient eligibility

About

Assessing postoperative pain after ropivacin 0.5% spray in the abdominal cavity during laparoscopic surgery.

Enrollment: 120 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Appendectomy or cholecystectomy surgery

Exclusion criteria

• Allergy to local anesthetics
• Intolerance to tramadol HCl
• Patient with peritonitis
• Pregnant women
• Surgery without laparoscopy
• Chronic pain before the operation

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

120 participants in 2 patient groups, including a placebo group

Ropivacaïne 0,5%

Active Comparator group

Description:

3 mg/kg of ropivacaine 0.5% sprayed into the abdominal cavity

Treatment:

Drug: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery

NaCl 0,9%

Placebo Comparator group

Description:

NaCl 0,9% sprayed into the abdominal cavity

Treatment:

Drug: Ropivacaïne 0,5% for appendectomy or cholecystectomy surgery